Physician profile
David Barbat
NPI 1770934754
$8,547.02
in general payments reported to CMS, 2019-2025
14 companies · $254 in 2025
The $254 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $4,832 · 2023: $3,277 · 2024: $184 · 2025: $254.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,022 · Education: $1,000 · Food and Beverage: $694.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,021.64 |
| Education | $1,000.00 |
| Food and Beverage | $693.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,112.25 | 2022-2023 | Da Vinci Surgical System, Davinci Xi |
| Zimmer Biomet Holdings, INC. | $936.12 | 2023-2025 | Advantagerib, Ribfix Blu Advantage |
| Csl Behring | $125.00 | 2025 | Kcentra |
| Smith+Nephew, INC. | $103.16 | 2023-2024 | Grafix Pl, Pico 7, Renasys Go V2 Home |
| Integra Lifesciences Corporation | $34.39 | 2024 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Hologic Sales and Service, LLC | $33.50 | 2024 | Coolseal Generator |
| Acera Surgical, INC. | $29.42 | 2025 | Restrata Wound Matrix |
| Aroa Biosurgery Incorporated | $27.81 | 2023 | |
| Mimedx Group, INC. | $27.71 | 2025 | |
| W. L. Gore & Associates, INC. | $26.83 | 2023 | Gore Enform Preperitoneal Biomaterial |
| Vertex Pharmaceuticals Incorporated | $25.43 | 2025 | |
| Ipsen Biopharmaceuticals, INC | $24.57 | 2025 | Iqirvo |
| Kerecis Limited | $20.42 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Pacira Pharmaceuticals Incorporated | $20.41 | 2024 | Iovera, Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Barbat listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.